A detailed history of State Board Of Administration Of Florida Retirement System transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 24,544 shares of ALLO stock, worth $55,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,544
Previous 24,544 -0.0%
Holding current value
$55,714
Previous $57,000 19.3%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$2.23 - $4.38 $2,453 - $4,818
1,100 Added 4.69%
24,544 $57,000
Q1 2024

May 08, 2024

SELL
$2.92 - $5.63 $3,212 - $6,193
-1,100 Reduced 4.48%
23,444 $104,000
Q4 2023

Feb 09, 2024

BUY
$2.28 - $3.5 $2,143 - $3,290
940 Added 3.98%
24,544 $78,000
Q3 2023

Nov 08, 2023

BUY
$3.17 - $5.96 $507 - $953
160 Added 0.68%
23,604 $74,000
Q4 2022

Feb 07, 2023

BUY
$5.62 - $11.11 $1,067 - $2,110
190 Added 0.82%
23,444 $147,000
Q2 2022

Aug 05, 2022

BUY
$6.78 - $12.28 $474 - $859
70 Added 0.3%
23,254 $265,000
Q4 2021

Feb 08, 2022

BUY
$13.13 - $24.52 $6,565 - $12,260
500 Added 2.2%
23,184 $346,000
Q2 2021

Aug 10, 2021

BUY
$23.49 - $35.8 $25,533 - $38,914
1,087 Added 5.03%
22,684 $592,000
Q1 2021

May 10, 2021

SELL
$25.79 - $39.02 $7,737 - $11,706
-300 Reduced 1.37%
21,597 $762,000
Q3 2020

Nov 09, 2020

BUY
$32.38 - $44.96 $122,072 - $169,499
3,770 Added 20.8%
21,897 $826,000
Q2 2020

Aug 07, 2020

BUY
$18.39 - $54.04 $333,355 - $979,583
18,127 New
18,127 $776,000
Q1 2020

May 05, 2020

SELL
$18.22 - $28.25 $170,448 - $264,278
-9,355 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$24.82 - $31.4 $21,345 - $27,004
860 Added 10.12%
9,355 $243,000
Q2 2019

Aug 05, 2019

BUY
$25.56 - $31.09 $217,132 - $264,109
8,495 New
8,495 $228,000

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.